Provided by Tiger Trade Technology Pte. Ltd.

CDT Equity

2.86
-0.0400-1.38%
Post-market: 3.020.1556+5.44%19:43 EDT
Volume:81.26K
Turnover:249.24K
Market Cap:2.25M
PE:-0.01
High:3.40
Open:2.99
Low:2.84
Close:2.90
52wk High:3,460.60
52wk Low:2.53
Shares:786.70K
Float Shares:758.90K
Volume Ratio:2.77
T/O Rate:10.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-239.1859
EPS(LYR):-11,778.9790
ROE:-69.68%
ROA:-23.44%
PB:0.02
PE(LYR):0.00

Loading ...

What's Going On With CDT Equity Shares On Monday?

Benzinga_recent_news
·
Apr 14

Top News Today/Canada: Liberals Within Reach of Majority Government

Dow Jones
·
Apr 09

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

GlobeNewswire
·
Apr 07

BRIEF-CDT Equity Files For Non-Timely 10-K With US SEC

Reuters
·
Apr 02

Top News Today/Canada: March Manufacturing PMI Slips to 50

Dow Jones
·
Apr 02

CDT Equity: for Year Ended Dec 31, 2025, Anticipates Net Loss Will Increase by About $21.3 Million

THOMSON REUTERS
·
Apr 02

CDT Equity delays annual report filing, cites incomplete financial statement information

Reuters
·
Apr 02

Top Premarket Decliners

MT Newswires Live
·
Mar 31

CDT Equity files Form 3 initial beneficial ownership statement for Mark Taylor

Reuters
·
Mar 31

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
Mar 27

CDT Equity Inc trading halted, news pending

TIPRANKS
·
Mar 27

CDT Equity expands Tapinarof intellectual property portfolio with patent filings

TIPRANKS
·
Mar 26

CDT Equity Inc - Files Two New Patent Applications for Tapinarof

THOMSON REUTERS
·
Mar 26

CDT Equity files two tapinarof patent applications; IP portfolio expands due to combination therapy and cocrystal claims

Reuters
·
Mar 26

BRIEF-Cdt Equity Inc. Announces Reverse Stock Split

Reuters
·
Mar 25

CDT Equity approves 1-for-25 reverse stock split; consolidation effective March 26, 2026

Reuters
·
Mar 25

CDT Equity Inc - Board Approves 1-for-25 Reverse Stock Split

THOMSON REUTERS
·
Mar 25

CDT Equity plans targeted preclinical validation studies to support early-stage out-licensing in rare diseases

Reuters
·
Mar 23

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

GlobeNewswire
·
Mar 23

BRIEF-Cdt Equity Stockholders Approve All Proposals At Special Meeting, Positioning The Company For Next Phase Of Growth

Reuters
·
Mar 18